Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Philip

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cytotherapy|July 6, 2016
Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigyUlrike Mock, Lauren Nickolay, Brian Philip, et al.
Blood|December 30, 2017
An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myelomaLydia Lee, Benjamin Draper, Neil Chaplin, et al.
Nature Medicine|November 14, 2017
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignanciesPaul M Maciocia, Patrycja A Wawrzyniecka, Brian Philip, et al.
Cancer Discovery|May 1, 2020
<i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication StressTheresa E León, Tanya Rapoz-D'Silva, Cosetta Bertoli, et al.
Cancer Research|July 18, 2015
Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell ImmunotherapiesLaurent Poirot, Brian Philip, Cécile Schiffer-Mannioui, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cytotherapy|July 6, 2016
Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigyUlrike Mock, Lauren Nickolay, Brian Philip, et al.
Blood|December 30, 2017
An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myelomaLydia Lee, Benjamin Draper, Neil Chaplin, et al.
Nature Medicine|November 14, 2017
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignanciesPaul M Maciocia, Patrycja A Wawrzyniecka, Brian Philip, et al.
Cancer Discovery|May 1, 2020
<i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication StressTheresa E León, Tanya Rapoz-D'Silva, Cosetta Bertoli, et al.
Cancer Research|July 18, 2015
Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell ImmunotherapiesLaurent Poirot, Brian Philip, Cécile Schiffer-Mannioui, et al.
Pageof 2